Home » Topics » Regulatory » Patents

Patents
RSS

S1P1 receptor agonists in development at GSK

Aug. 13, 2009

Sanofi-aventis synthesizes P2Y12 receptor antagonists useful in antiplatelet therapy

Aug. 13, 2009

Kissei describes COMT inhibitors for the treatment of Parkinson's disease

Aug. 13, 2009

Abbott discloses histamine H3 receptor ligands for the treatment of ADHD

Aug. 13, 2009

Selective A2A receptor agonists claimed by PGxHealth for autoimmune conditions

Aug. 12, 2009

PI3K inhibitors presented by UCB for inflammatory and autoimmune diseases

Aug. 12, 2009

Functional Genetics developing TSG101 inhibitors for viral infections

Aug. 12, 2009

Abbott describes PAMs of neuronal nicotinic receptors for cognition disorders

Aug. 12, 2009

Nicotinic receptor agonists in development at Pfizer for ADHD and other disorders

Aug. 12, 2009

Amgen discloses new CDK4 and CDK6 inhibitors for the treatment of cancer

Aug. 12, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...